Literature DB >> 16950486

Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.

S Joshi1, S K Amarnath.   

Abstract

Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A is being increasingly reported. The minimum inhibitory concentrations (MICs) of ciprofloxacin, ofloxacin, levofloxacin and gatifloxacin against S. typhi and S. paratyphi A were compared. Fifty blood culture isolates, 25 S. typhi and 25 S. paratyphi A, were studied. The MICs were determined by the agar dilution method. Disc diffusion was done for the fluoroquinolones and other antibiotics. Nalidixic acid resistance was seen in 21/25 S. paratyphi A and 17/25 S. typhi isolates, and these had higher MICs to fluoroquinolones. Five S. typhi and six S. paratyphi A were fully resistant to ciprofloxacin (MIC >2 microg/l). No multidrug resistance was seen in S. typhi. The absence of multidrug resistance and presence of fluoroquinolone resistance warrants a review of therapy for enteric fever.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950486     DOI: 10.1016/j.trstmh.2006.05.009

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  17 in total

1.  Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected].

Authors:  Ferric C Fang
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

2.  Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia.

Authors:  Samuel Kariuki; Gunturu Revathi; John Kiiru; Doris M Mengo; Joyce Mwituria; Jane Muyodi; Agnes Munyalo; Yik Y Teo; Kathryn E Holt; Robert A Kingsley; Gordon Dougan
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

Review 3.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 4.  WITHDRAWN: Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever).

Authors:  Emmanuel E Effa; Hasifa Bukirwa
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

5.  Quinolone and cephalosporin resistance in enteric Fever.

Authors:  Malini Rajinder Capoor; Deepthi Nair
Journal:  J Glob Infect Dis       Date:  2010-09

Review 6.  Salmonella serovars from foodborne and waterborne diseases in Korea, 1998-2007: total isolates decreasing versus rare serovars emerging.

Authors:  Shukho Kim
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

7.  A comparative study of efficacy and safety of azithromycin and ofloxacin in uncomplicated typhoid Fever: a randomised, open labelled study.

Authors:  Manish Chandey; A S Multani
Journal:  J Clin Diagn Res       Date:  2012-08-25

8.  Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.

Authors:  Amit Arjyal; Buddha Basnyat; Samir Koirala; Abhilasha Karkey; Sabina Dongol; Krishna Kumar Agrawaal; Nikki Shakya; Kabina Shrestha; Manish Sharma; Sanju Lama; Kasturi Shrestha; Nely Shrestha Khatri; Umesh Shrestha; James I Campbell; Stephen Baker; Jeremy Farrar; Marcel Wolbers; Christiane Dolecek
Journal:  Lancet Infect Dis       Date:  2011-04-29       Impact factor: 25.071

9.  Bloodstream infection among children presenting to a general hospital outpatient clinic in urban Nepal.

Authors:  Rahul Pradhan; Umesh Shrestha; Samir C Gautam; Stephen Thorson; Kabindra Shrestha; Bharat K Yadav; Dominic F Kelly; Neelam Adhikari; Andrew J Pollard; David R Murdoch
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

Review 10.  A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis.

Authors:  Durrane Thaver; Anita K M Zaidi; Julia Critchley; Asma Azmatullah; Syed Ali Madni; Zulfiqar A Bhutta
Journal:  BMJ       Date:  2009-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.